| Date | Title | | | 05/15/13 | Synta Announces Presentations at the 2013 American Society for Clinical Oncology (ASCO) Annual Meeting| LEXINGTON, Mass.--(BUSINESS WIRE)--May. 15, 2013--
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced scheduled
presentations at the 2013 American Society for Clinical Oncology (ASCO)
Annual Meeting, which is taking place May 31 – June 4 in Chicago.
GALAXY-1 interim results
“A randomized study of ganetespib, a heat shock protein 90 inhibitor, in
combination with docetaxel versus docetaxel alone for second-line
therapy of lu... |
|  | | 04/30/13 | Synta Provides Clinical Updates and Reports First Quarter 2013 Financial Results| LEXINGTON, Mass.--(BUSINESS WIRE)--Apr. 30, 2013--
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today provided clinical
updates and reported financial results for the first quarter ended March
31, 2013.
Clinical Updates
Interim results from the randomized GALAXY-1 Phase 2b/3 trial, which
compares docetaxel with and without Synta’s investigational Hsp90
inhibitor ganetespib for the second-line treatment of advanced non-small
ce... |
| | | 04/22/13 | Synta Announces First Patients Treated in Pivotal GALAXY-2 Trial Evaluating Ganetespib in Advanced Non-Small Cell Lung Cancer| LEXINGTON, Mass.--(BUSINESS WIRE)--Apr. 22, 2013--
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that the
first patients have been treated in the randomized GALAXY-2 Phase 3
trial designed to evaluate docetaxel plus ganetespib, its
investigational Hsp90 inhibitor, versus docetaxel alone for the
second-line treatment of non-small cell lung adenocarcinoma. The study
will enroll approximately 500 patients from about 140 cancer treatment
... |
| | | 04/16/13 | Synta to Host Conference Call and Webcast of First Quarter 2013 Financial Results on April 30, 2013| LEXINGTON, Mass.--(BUSINESS WIRE)--Apr. 16, 2013--
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will
release its first quarter 2013 financial results before the market opens
on Tuesday, April 30, 2013.
Following the issuance of the press release, management will conduct a
conference call at 10:00 a.m. (EDT) that morning to review the Company's
first quarter financial results. The conference call will be webcast
live o... |
| |
|
